Researchers find new way to diagnose liver cancer
Researchers in China have identified gut microbiota as a new biomarker of liver cancer. Hepatocellular carcinoma (HCC) is the most common type of liver cancer and the third leading cause of cancer-related deaths worldwide. Due to the absence of specific symptoms in early stages and the lack of diagnostic markers, most patients with HCC are often diagnosed at an advanced stage. Researchers from the School of Medicine, Zhejiang University, and the First Affiliated Hospital of Zhengzhou University focused on the different gut microbial diversity in healthy people and patients, and came up with a new solution for the early diagnosis of liver cancer. Human gut microbiota helps the body digest certain foods that the stomach and small intestine cannot. The research was recently published in the medical journal Gut. The researchers said more data and further studies are needed to confirm the validity and reliability of the model.